Biotransformation and Metabolism Pathways Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Biotransformation and Metabolism Pathways. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Biotransformation and Metabolism Pathways Indian Medical PG Question 1: The cytochrome involved in monooxygenase-mediated detoxification of drugs is:
- A. Cyt P 450 (Correct Answer)
- B. Cytochrome b5
- C. Cytochrome c
- D. Cytochrome oxidase
Biotransformation and Metabolism Pathways Explanation: ***Cyt P 450***
- **Cytochrome P450 (CYP450)** enzymes are a superfamily of heme-containing monooxygenases primarily responsible for the **metabolism of xenobiotics**, including the detoxification of drugs.
- They catalyze oxidation reactions, introducing a hydroxyl group to substrates, which typically increases their **hydrophilicity** and facilitates excretion.
*Cytochrome c*
- **Cytochrome c** is a component of the **electron transport chain** in mitochondria, primarily involved in cellular respiration and energy production.
- It acts as an **electron carrier** between Complex III and Complex IV, not directly in drug detoxification.
*Cytochrome b5*
- **Cytochrome b5** participates in various metabolic reactions, including **fatty acid desaturation** and cholesterol biosynthesis, and can sometimes assist CYP450 enzymes.
- However, it does not function as a primary monooxygenase for drug detoxification itself.
*Cytochrome oxidase*
- **Cytochrome oxidase** (Complex IV) is the terminal enzyme in the **electron transport chain**, responsible for the reduction of oxygen to water.
- Its main role is in cellular respiration, and it is not directly involved in drug monooxygenation or detoxification.
Biotransformation and Metabolism Pathways Indian Medical PG Question 2: What is the primary role of Cytochrome P450 enzymes in the liver?
- A. Lipid transport
- B. Oxidation of drugs (Correct Answer)
- C. Carbohydrate synthesis
- D. Protein degradation
Biotransformation and Metabolism Pathways Explanation: ***Oxidation of drugs***
- **Cytochrome P450 enzymes** are a superfamily of monooxygenases that primarily catalyze the **oxidation of various endogenous and exogenous substrates**, including drugs [1, 2].
- This oxidative metabolism is a key step in detoxification and elimination of foreign compounds from the body [1].
*Lipid transport*
- **Lipid transport** is primarily facilitated by **lipoproteins** and specific **transport proteins** in the blood and within cells.
- While P450 enzymes can metabolize some lipids, their primary role is not in lipid transport [2].
*Carbohydrate synthesis*
- **Carbohydrate synthesis**, or **gluconeogenesis**, is mainly carried out by enzymes such as **pyruvate carboxylase** and **fructose-1,6-bisphosphatase**.
- Cytochrome P450 enzymes do not play a direct role in the synthesis of carbohydrates.
*Protein degradation*
- **Protein degradation** is largely mediated by the **ubiquitin-proteasome system** and **lysosomal pathways**.
- Cytochrome P450 enzymes are not directly involved in breaking down proteins into smaller peptides or amino acids.
Biotransformation and Metabolism Pathways Indian Medical PG Question 3: Which is true for glucuronidation:
- A. Done by CYP enzyme
- B. Phase I reaction
- C. Phase II reaction (Correct Answer)
- D. Water solubility is decreased
Biotransformation and Metabolism Pathways Explanation: ***Phase II reaction***- **Glucuronidation** is a major **Phase II** metabolic pathway that conjugates a glucuronic acid molecule to a **lipophilic substance** [1]- This process significantly increases the **water solubility** of the substance, facilitating its excretion from the body [1, 2]- Catalyzed by **UDP-glucuronosyltransferases (UGTs)**, a family of conjugation enzymes [1]*Done by CYP enzyme*- **CYP (cytochrome P450)** enzymes are primarily involved in **Phase I** metabolic reactions, which typically functionalize compounds through oxidation, reduction, or hydrolysis [1]- Glucuronidation is catalyzed by **UDP-glucuronosyltransferases (UGTs)**, not CYP enzymes [1]*Phase I reaction*- **Phase I reactions** (e.g., oxidation, reduction, hydrolysis) introduce or expose polar functional groups on xenobiotics [1]- Glucuronidation is a **conjugation reaction**, characteristic of **Phase II metabolism**, not Phase I [1]*Water solubility is decreased*- Glucuronidation involves the attachment of a **hydrophilic glucuronic acid** molecule to the substrate [1]- This conjugation significantly **increases the water solubility** of the metabolite, which is essential for its efficient urinary or biliary excretion [1, 2]- The addition of the polar glucuronic acid group makes lipophilic compounds more water-soluble [1]
Biotransformation and Metabolism Pathways Indian Medical PG Question 4: A factor that is likely to increase the duration of action of a drug that is partially metabolized by CYP3A4 in the liver is:
- A. Chronic administration of phenobarbital with the drug
- B. Displacement from tissue binding sites by another drug
- C. Chronic administration of rifampicin
- D. Chronic administration of cimetidine with the drug (Correct Answer)
Biotransformation and Metabolism Pathways Explanation: ***Chronic administration of cimetidine with the drug***
- **Cimetidine** is a potent inhibitor of various **cytochrome P450 (CYP450) enzymes**, including **CYP3A4**.
- By inhibiting the metabolism of a drug predominantly metabolized by **CYP3A4**, cimetidine will increase its plasma concentration and extend its **duration of action**.
*Chronic administration of phenobarbital with the drug*
- **Phenobarbital** is a strong **inducer of CYP450 enzymes**, including **CYP3A4**.
- Induction would accelerate the metabolism of the drug, thus **decreasing its duration of action**, not increasing it.
*Displacement from tissue binding sites by another drug*
- Displacement from tissue binding sites would primarily increase the **free fraction of the drug in the plasma**, leading to a more rapid distribution to eliminating organs and potentially **shorter duration of action** if elimination is extraction-limited.
- This mechanism does not directly impact the **metabolic rate** unless clearance is significantly altered through increased availability for metabolism.
*Chronic administration of rifampicin*
- **Rifampicin** is a potent **inducer of CYP3A4** and other CYP enzymes.
- Its administration would lead to **increased metabolism** of the co-administered drug, thereby **reducing its duration of action**.
Biotransformation and Metabolism Pathways Indian Medical PG Question 5: All are true for cytochrome P450 enzymes EXCEPT:
- A. Synthesize amino acids (Correct Answer)
- B. Involved in drug metabolism
- C. Present mainly in the liver
- D. Part of Phase I metabolism
Biotransformation and Metabolism Pathways Explanation: ***Synthesize amino acids***
- Cytochrome P450 enzymes are primarily involved in the **metabolism of xenobiotics** and endogenous compounds, not in the synthesis of amino acids.
- **Amino acid synthesis** occurs through different metabolic pathways involving various enzymes distinct from the cytochrome P450 system.
*Involved in drug metabolism*
- Cytochrome P450 enzymes are a major group of enzymes crucial for the **biotransformation of numerous drugs** and other foreign compounds.
- They typically catalyze **oxidation reactions**, preparing drugs for excretion.
*Present mainly in the liver*
- While present in many tissues, the **highest concentration and diversity** of cytochrome P450 enzymes are found in the **liver**, which is the primary site of drug metabolism.
- They are also found in the gastrointestinal tract, kidney, lung, and brain, but to a lesser extent.
*Part of Phase I metabolism*
- Cytochrome P450 enzymes are the **principal enzymes responsible for Phase I reactions** in drug metabolism.
- **Phase I metabolism** generally involves reduction, oxidation, or hydrolysis reactions to introduce polar groups to the drug molecule.
Biotransformation and Metabolism Pathways Indian Medical PG Question 6: A patient on warfarin has a high INR. Which drug likely caused this?
- A. Amiodarone (Correct Answer)
- B. Phenytoin
- C. Carbamazepine
- D. Rifampicin
Biotransformation and Metabolism Pathways Explanation: ***Amiodarone***
- Amiodarone is a well-known inhibitor of **CYP2C9**, the primary enzyme responsible for the metabolism of **S-warfarin**, the more potent enantiomer of warfarin.
- Inhibition of warfarin metabolism leads to increased warfarin levels, thereby enhancing its anticoagulant effect and causing a **higher INR**.
*Phenytoin*
- Phenytoin is an **enzyme inducer**, primarily of **CYP2C9** and **CYP3A4**.
- Its interaction with warfarin typically leads to **decreased warfarin levels** and a **lower INR**, reducing the anticoagulant effect.
*Carbamazepine*
- Carbamazepine is a potent **enzyme inducer**, particularly of **CYP3A4** and **CYP2C9**.
- Like phenytoin, it generally leads to **increased warfarin metabolism** and a **reduced INR**, thereby decreasing its anticoagulant efficacy.
*Rifampicin*
- Rifampicin is a strong **inducer of hepatic cytochrome P450 enzymes**, especially **CYP3A4** and **CYP2C9**.
- Its co-administration with warfarin significantly **increases warfarin metabolism**, resulting in **lower warfarin concentrations** and a **decreased INR**.
Biotransformation and Metabolism Pathways Indian Medical PG Question 7: Which of the following drugs is known to have low first pass metabolism?
- A. Lidocaine
- B. Propranolol
- C. Theophylline (Correct Answer)
- D. Morphine
Biotransformation and Metabolism Pathways Explanation: ***Theophylline***
- **Theophylline** exhibits **low first-pass metabolism**, meaning a significant portion of the orally administered drug reaches systemic circulation unchanged.
- This characteristic contributes to its relatively **high bioavailability** when given orally.
*Lidocaine*
- **Lidocaine** undergoes extensive **first-pass metabolism** in the liver, leading to very low oral bioavailability.
- Due to this, it is typically administered **parenterally** (e.g., intravenously or topically) to achieve therapeutic concentrations.
*Propranolol*
- **Propranolol** is known for its significant **first-pass metabolism**, which results in a much lower bioavailability after oral administration compared to intravenous.
- This extensive metabolism necessitates higher oral doses to achieve the same therapeutic effect as parenteral administration.
*Morphine*
- **Morphine** also undergoes substantial **first-pass metabolism** in the liver, where it is primarily glucuronidated.
- This leads to a lower oral bioavailability compared to other routes of administration and contributes to a higher oral dose requirement.
Biotransformation and Metabolism Pathways Indian Medical PG Question 8: Which substance is conjugated in the liver and is the final product of heme catabolism?
- A. Bilirubin (Correct Answer)
- B. Hemoglobin
- C. Myoglobin
- D. Biliverdin
Biotransformation and Metabolism Pathways Explanation: ***Bilirubin***
- **Bilirubin** is the primary end-product of **heme catabolism**, which largely occurs in the body's reticuloendothelial system (e.g., spleen, liver).
- Unconjugated bilirubin is transported to the **liver**, where it undergoes **conjugation** with glucuronic acid, making it water-soluble for excretion in bile.
*Myoglobin*
- **Myoglobin** is an oxygen-binding protein found in **muscle cells**, similar to hemoglobin in red blood cells.
- While it contains a heme group, it is not a direct product of heme catabolism in the same way bilirubin is, but rather a separate functional protein.
*Hemoglobin*
- **Hemoglobin** is the protein in red blood cells responsible for **oxygen transport**, and it contains four heme groups.
- While heme is derived from hemoglobin breakdown, hemoglobin itself is the precursor to heme catabolism, not the catabolic product.
*Biliverdin*
- **Biliverdin** is an **intermediate product** in the catabolism of heme, formed directly from heme by the enzyme **heme oxygenase**.
- It is rapidly reduced to bilirubin by **biliverdin reductase**, making bilirubin the primary end-product that undergoes further processing in the liver.
Biotransformation and Metabolism Pathways Indian Medical PG Question 9: Bile salts undergo conjugation for enhanced solubility:
- A. After conjugation with derived proteins
- B. After conjugation with lysine
- C. After conjugation with taurine and glycine (Correct Answer)
- D. After conjugation with betaglucuronic acid
Biotransformation and Metabolism Pathways Explanation: ***After conjugation with taurine and glycine***
- This statement accurately describes the most common conjugation pathway for bile acids, increasing their **amphipathic properties** and solubility.
- Conjugation with these amino acids forms **bile salts** (e.g., glycocholate, taurocholate), which are essential for **micelle formation** and fat digestion.
- This is the primary mechanism by which bile acids become bile salts with enhanced solubility.
*After conjugation with betaglucuronic acid*
- While bile acids do undergo conjugation for increased solubility, they are primarily conjugated with glycine or taurine, not beta-glucuronic acid.
- Conjugation with beta-glucuronic acid is a common detoxification pathway for many xenobiotics and bilirubin, but not the primary method for bile acids.
*After conjugation with derived proteins*
- Bile salts are primarily steroid derivatives and are not conjugated with derived proteins.
- The purpose of conjugation is to increase hydrophilicity, which proteins would not achieve in this context.
*After conjugation with lysine*
- Lysine is an amino acid but is not involved in the conjugation of bile acids.
- Bile acid conjugation specifically uses the amino acids glycine and taurine.
Biotransformation and Metabolism Pathways Indian Medical PG Question 10: Which of the following statements about the biodisposition of penicillins and cephalosporins is NOT accurate?
- A. Procaine penicillin G is used for intramuscular injection
- B. Nafcillin and ceftriaxone are eliminated mainly by biliary secretion
- C. Oral bioavailability is affected by lability to gastric acid
- D. Renal tubular reabsorption of beta-lactams is inhibited by probenecid (Correct Answer)
Biotransformation and Metabolism Pathways Explanation: ***Renal tubular reabsorption of beta-lactams is inhibited by probenecid*** - Probenecid inhibits the **active tubular secretion** of beta-lactam antibiotics, not their reabsorption, thereby increasing their half-life and maintaining higher plasma concentrations [3]. - This interaction is clinically useful for prolonging the antibacterial effect of penicillins and cephalosporins. *Oral bioavailability is affected by lability to gastric acid* - Many early penicillins, such as **penicillin G**, are highly susceptible to degradation by stomach acid, leading to poor oral bioavailability [2]. - This necessitates their administration via intravenous or intramuscular routes, or the development of **acid-stable analogs** like penicillin V [2]. *Procaine penicillin G is used for intramuscular injection* - **Procaine penicillin G** is formulated for intramuscular injection to create a **depot effect**, allowing for slow absorption and prolonged therapeutic plasma concentrations. - The procaine component also acts as a **local anesthetic**, reducing the pain associated with a large-volume intramuscular injection [1]. *Nafcillin and ceftriaxone are eliminated mainly by biliary secretion* - **Nafcillin** and **ceftriaxone** are indeed notable among beta-lactam antibiotics for their significant elimination through the biliary tract. - This route of excretion makes them particularly useful in patients with **renal impairment**, as their elimination is less dependent on kidney function.
More Biotransformation and Metabolism Pathways Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
